Technology
-
和黃醫藥（13.HK）—— 研發驅動的生物製藥公司
公司背景與現狀 和黃醫藥（Hutchmed，13.HK）是一家專注於創新藥物研發的生物製藥公司，業務涵蓋腫瘤、免疫疾病及其他重大病症的治療方案。公司擁有豐富的研發管線，涵蓋靶向治療、免疫治療及其他創新藥物。近年來，隨著全球生物科技行業的快速發展，和黃醫藥積極拓展國際市場，並與多家全球藥企合作，推動新藥的商業化進程。公司在中國、美國及歐洲市場均有所布局，並希望通過技術創新及戰略合作擴大市場佔有率。 股價表現與基本面 截至最新交易日，和黃醫藥（13.HK）股價約 23.70 港元，較前一交易日上漲 2.16%。過去一年股價最高達 34.80 港元，最低則為 18.36 港元，顯示市場對生物科技企業仍具高度關注。公司市值約 190…
-
ASMPT Ltd（522.HK）—— 半導體設備龍頭的挑戰與機遇
市場地位與現狀 ASMPT Ltd（522.HK）一直是亞洲乃至全球半導體設備領域的重要玩家，主打半導體封裝及表面貼裝技術（SMT）。作為一家擁有超過 40 年歷史的企業，其技術積累深厚，在晶圓加工、封裝及組裝設備方面具備領先優勢。然而，近年來全球半導體週期波動劇烈，加上行業競爭加劇，ASMPT 的市場表現也受到影響。 股價表現與基本面 近期 ASMPT 股價於 54 港元…
-
An short introduction to the new Remarkable Paper Pro | (6) How can students mark good use of a Remarkable table?
The ReMarkable writing tablet can be a fantastic tool for students, offering…
-
An short introduction to the new Remarkable Paper Pro | (5) Is the reMarkable Worth It for Professionals?
Is the reMarkable Worth It for Professionals? For professionals, investing in a…
-
An short introduction to the new Remarkable Paper Pro | (4) Is the reMarkable Worth It for Students?
Is the reMarkable Worth It for Students? Investing in a reMarkable tablet…
-
An short introduction to the new Remarkable Paper Pro | (3) Comparison between Remarkable 2 and Remarkable Paper Pro
Comparing the reMarkable 2 and reMarkable Paper Pro reMarkable has made significant…
-
An short introduction to the new Remarkable Paper Pro | (2) What is the new Remarkable Paper Pro
Introduction to reMarkable and Its New Paper Pro reMarkable continues to innovate…
-
An short introduction to the new Remarkable Paper Pro | (1) What is Remarkable firstly?
Introduction to reMarkable and Its Writing Tablet reMarkable is a Norwegian tech…
-
A Short Summary on Apple WWDC 2024 and the Apple Intelligence
Apple’s latest Worldwide Developers Conference keynote concluded with several significant announcements. Among…
-
(2) What is OKLO? | How does its IPO perform?
“With exceptionally low redemptions, >$300M in capitalisation, and dedicated founders and key…
